Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × enfortumab vedotin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 9 Urinary Bladder Neoplasms 3 Urethral Neoplasms 1 Ureteral Neoplasms 1 Peripheral Nervous System Diseases 1 Neoplasm Metastasis 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Bladder Cancer 1

Interventions

Gemcitabine 7 erdafitinib 4 Mitomycin 4 dodecyl maltoside 2 Docetaxel 2 pirarubicin 1 hydroxycamptothecinum 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Epirubicin 1 Drainage 1 Cystoscopy 1 BCG Vaccine 1 Accelerometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡